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Alberto Raggi5, Matilde Leonardi5, Eduard Vieta6 and Somnath Chatterji7Abstract
Background: This study identifies a set of psychosocial difficulties that are associated with short term changes in
health outcomes across a heterogeneous set of brain disorders, neurological and psychiatric.
Methods: Longitudinal observational study over approximately 12 weeks with three time points of assessment and
741 patients with bipolar disorders, depression, migraine, multiple sclerosis, parkinson’s disease, stroke and traumatic
brain injury. The data on disability was collected with the checklist of the International Classification of Functioning,
Disability and Health. The selected health outcomes were the Short Form 36 and the World Health Organization
Disability Assessment Schedule. Multilevel models for change were applied controlling for age, gender and
disease severity.
Results: The psychosocial difficulties that explain the variability and change over time of the selected health
outcomes were energy and drive, sleep, and emotional functions, and a broad range of activities and participation
domains, such as solving problems, conversation, areas of mobility and self-care, relationships, community life and
recreation and leisure.
Conclusions: Our findings are of interest to researchers and clinicians for interventions and health systems
planning as they show that in addition to difficulties that are diagnostic criteria of these disorders, there are other
difficulties that explain small changes in health outcomes over short periods of time.
Keywords: Psychosocial, Psychiatric disorders, Neurological disorders, DisabilityBackground
The overall prevalence of brain disorders – by which we
mean neurological and psychiatric conditions – is very
high in Europe [1]. Twenty-seven percent of the European
population 18–65 years old are or have been affected by at
least one brain disorder in the past 12 months. In popula-
tion terms, it is estimated that between 78.5 and 87.1 mil-
lion persons are affected, and about one third of persons
with brain disorders have more than one [2].* Correspondence: a.cieza@soton.ac.uk
1Faculty of Social and Human Sciences, School of Psychology (Building 44),
University of Southampton, Highfield Campus, Southampton SO17 1BJ, UK
2Department of Medical Informatics, Biometry and Epidemiology –
IBE, Chair for Public Health and Health Services Research, Research Unit for
Biopsychosocial Health, Ludwig-Maximilians-University (LMU),
Munich, Germany
Full list of author information is available at the end of the article
© 2013 Cieza et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orCost-of-illness studies consistently show that the eco-
nomic and social costs of brain disorders are enormous
and are, for example, considerably larger than costs of
diabetes or cancer [3]. Although it is well known that
these costs are high, nonetheless there is also evidence
that the overall, personal, social and economic costs of
brain disorders have been underestimated for decades
because of the lack of valid and relevant information
[1,3,4]. Cost-of-illness studies usually do not include the
full range of psychosocial difficulties that actually shape
the experience of persons with these disorders, affect
their quality of life and determine the scope and fre-
quency of clinical interventions. Getting this information
is therefore vital and this study will focus on identifying
psychosocial difficulties that are associated with a het-
erogeneous range of brain disorders.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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highlighted the underappreciated significance of the psy-
chosocial burden of living with brain disorders and made
clear that difficulties in participating in personal, family
and social life greatly contribute to the burden of brain
disorders. The WHO’s 2006 report on neurological dis-
orders [6] notes that not only the burden of these disor-
ders for the person, but also the impact on families and
communities have to be taken into account. Moreover,
the burden of living with neurological disorders is
heightened by widespread stigma and discrimination
created by the attitudes of those around the individual,
both friends and strangers. These conclusions are sup-
ported by the country-by-country data collated in
WHO’s 2005 Mental Health Atlas [7]. This states that
the single most important research need for intervention
planning and management is epidemiological data that is
relevant, not merely to the prevalence of brain disorders,
but to the prevalence of psychosocial problems that
people with these disorders will experience over their
lives. This was also supported by WHO’s 2004 Atlas for
Neurological Disorders [8].
There are a few European studies that include descrip-
tions and assessments of psychosocial difficulties associ-
ated with brain disorders [1]. Some of these studies have
used the WHO’s International Classification of Function-
ing, Disability and Health (ICF) [9] as the framework for
describing psychosocial difficulties of brain disorders,
which in the ICF are called “disabilities” [10-14]. Since
the ICF is an etiologically neutral classification, it has
the great advantage that it can be used for describing the
psychosocial difficulties of any brain disorder. Based on
the need to carry out studies that go beyond the com-
mon practice of focusing on a single brain disorder, or
combinations of two of them [1,15], our understanding
of psychosocial difficulties associated with brain disor-
ders can take advantage of the ICF to structure a sys-
tematic description of these difficulties. In addition, the
ICF also includes environmental factors, understood as
determinants that can have a potential positive or nega-
tive influence on health outcomes. In other words, they
can be facilitators or barriers. The use of the ICF for
data collection is thus further justified as it allows for
the identification of environmental determinants.
There is also a need for studies that address psycho-
social difficulties based on a longitudinal design. Our
clinical experience teaches us that the psychosocial diffi-
culties of persons with brain disorders fluctuate with the
stage of the disease, not infrequently over short periods
of time. It is common, for example, to observe changes
in the levels of energy and drive, fluctuations in emo-
tionality and in the extent to which the work perform-
ance is affected by the disease. An open question so far
is the extent to which those short-term fluctuations atany stage of the disease process affect general health out-
comes. This kind of information would be of considerable
value for interventions and health systems planning.
The aim of this study is, therefore, to identify a set of
psychosocial difficulties or disabilities using the ICF that
are associated with short term changes in health out-
comes across heterogeneous brain disorders.Methods
Study design
As part of a three year European Commission funded FP6
coordination action involving nine European countries
called ‘Measuring Health and Disability in Europe: sup-
porting policy development’ (MHADIE www.mhadie.it),
our study was a longitudinal observational investigation
on a convenience sample of persons with the verified
diagnosis of one of the following brain disorders: bipolar
disorders (BD), depression, migraine, multiple sclerosis
(MS), parkinson’s disease (PD), stroke and traumatic brain
injury (TBI).
The disorders selected for this study are both neuro-
logical and psychiatric in nature and heterogeneous
with respect to etiology, biochemical basis and signs and
symptoms. In addition, all of these disorders either have
a high global burden rating or are highly disruptive to a
person´s life.
The data for this study was collected in five study
centers in four countries. One study center was in the
Czech Republic, Italy, Slovenia and two in Spain. Data
collection was performed at three time points: baseline
(T0), approximately six weeks later (T1), and approxi-
mately twelve weeks later (T2). Since the time between
time points was irregularly spaced, actual time in days
from baseline is used as a time variable. Data on T1 was
collected between 22 and 84 days after baseline with a
mean of 44.17 and a median of 42 days, data on T2 be-
tween 55 and 147 days after baseline with a mean of
90.26 and a median of 88 days. Boxplots showing the
number of days between data collection time points for
each of the health conditions are presented in Figure 1.
The study protocol and the informed consent forms
were approved by the responsible Ethics Committees at
each center, namely the ethical committees of the
Instituto Nazionale Neurologico “Carlo Besta” in Milan,
Italy, the medical faculty of the Charles University in
Prague, Czech Republic, the Institute for Rehabilitation
in Ljubljana, Slovenia and the Hospital Universitario de
La Princesa in Madrid, Spain. The inclusion criteria for
patients were that the main diagnosis was one of the
seven selected brain disorders; that the patient was at
least 18 years old and had sufficient facility with the lan-
guage of the country to understand all aspects of the
study for purposes of consent; and that, finally, the
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Figure 1 Boxplots showing the number of days between data collection time points.
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http://www.biomedcentral.com/1471-244X/13/78patient agreed to participate and had signed the in-
formed consent form.Measures
The socio-demographic data recorded was gender, age,
years of formal education and current work status. Dis-
ease characteristics were specific for each health condi-
tion and the diagnosis was based on ICD-10 criteria.
The severity of each health condition was determined by
the following measures: Young Rating Scale of Mania
Total Score for BD; Beck Depression Inventory II - BDI
for depression; Migraine Disability Assessment Ques-
tionnaire (MIDAS) for migraine; Kurtzke Expanded Dis-
ability Status Scale (EDSS) for MS; Hoehn and Yahr
Scale for PD; the Rankin Scale for stroke; and Functional
Independence Measure (FIM) for TBI. The assignment
of a patient to a severity grade (Mild, Moderate, Severe)
was based on the distribution of the sample for the cor-
responding measure (Table 1).The data on disability was collected with the ICF
checklist [16]. This checklist is a selection of 128 cat-
egories from each of the four components of the ICF –
body functions (b), body structures (s), activities and
participation (d), and environmental factors (e). It has
been extensively used in several studies involving the ap-
plication of the ICF. The following are examples of ICF
categories from the different components: b134 Sleep
functions, s410 Structure of cardiovascular system, d330
Speaking and e310 Immediate family. To facilitate the
reading of the paper, we will not use the codes of the
ICF categories but only their title from now on.
The severity of a problem for each b, s and d category
was quantified by the ICF qualifier scale with response
options 0 (NO problem), 1 (MILD), 2 (MODERATE), 3
(SEVERE), and 4 (COMPLETE problem). For the e com-
ponent, the extent to which the category was a barrier
was quantified on a comparable 0 to 4 scale. To denote
an e category as a facilitator a positive sign (e.g. +2)
was added. The option 8 was used when the available
Table 1 Measures used to determine the severity for each brain disorder, and the assignment to the severity scale
according to the distribution of the sample
Measures High Disease
Severity
Moderate Disease
Severity
Mild Disease
Severity
Brain Disorders
Bipolar
Disorders
Young Rating Scale of Mania
Total Score
> 19 - Manic-
Episode Group
≥ 7 and≤ 19 - Subclinical
and Hypomania Group
< 7 - Euthymia
Group
Depression Beck Depression Inventory II - BDI > 28 ≥ 14 and≤ 28 < 14
Migraine Migraine Disability Assessment Questionnaire (MIDAS) > 20 ≥ 6 and≤ 20 < 6
Multiple
Sclerosis
Kurtzke Expanded Disability
Status Scale (EDSS)
> 5 ≥ 3 and≤ 5 < 3
Parkinson's Disease Hoehn and Yahr Scale = 3 or =4 = 2 or = 2.5 = 1 or = 1.5
Stroke Rankin Scale = 4 or =5 = 2 or = 3 = 0 or = 1
Traumatic Brain Injury Functional Independence
Measure (FIM)
>125 ≥ 115 and ≤125 < 115
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the problem, and the option 9 was used when the cat-
egory was not applicable to the patient.
For outcome measures, patients completed the Med-
ical Outcome Study Short Form 36 (SF-36) [17] and
the World Health Organization Disability Assessment
Schedule (WHODAS II) [18,19]. Both of these were used
as self-reported measures. The SF-36 is summarized by
a Physical Component Summary measure (PCS, range
0–100, with higher values indicating better physical
functioning) and a Mental Component Summary meas-
ure (MCS, range 0–100, with higher values indicating
better mental functioning). In addition, the General
Health (GH) Scale from the SF-36 was used as summary
for the patient’s rating of his or her general health (range
0–100, with higher values indicating better general
health).
The WHODAS II is a 36-item instrument developed
to assess activity limitations and participation restric-
tions in six domains (understanding and communicat-
ing, getting around, self-care, getting along with people,
life activities, and participation in society). Scores in the
six domains as well as a global disability level score from
0 (best) to 100 (worst) are provided.
Data collection procedures
Patient recruitment and data collection were performed
by health professionals at each study center. The health
professionals were trained for this in a structured three
day workshop performed at Neurological Institute C.
Besta Foundation IRCCS, Milan, Italy [20]. Consecutive
patients in the five study centers mentioned above were
recruited from September 2005 to May 2008 by the
trained health professionals, who were psychologists,
neurologists, psychiatrists and rehabilitation doctors.
The rating of the extent to which the patients had
problems in the ICF categories or the extent to whichenvironmental factors were barriers or facilitators was
based on the information obtained from structured in-
terviews held with each patient individually, as well as
from clinical records. As advised by the WHO, for each
patient only those ICF categories that are relevant were
rated. After documentation of the demographic informa-
tion and of the ICF categories contained in the ICF
checklist, the patients were asked to fill in the self-
reported questionnaires.
Data analysis
Descriptive statistics were used to characterize the study
population, and to describe, at each time point of assess-
ment, the four health outcomes, namely, the GH Scale,
the PCS, and the MCS of the SF-36 and the WHODAS
II global disability level score.
Boxplots were used to depict the change in within-
person variation of health outcomes from T0 to T1,
from T1 to T2 and from T0 to T2.
Data preparation
1) Response option 9 was set to 0 since when an ICF
category is not applicable for a person, it can be
assumed that it is not a problem.
2) Response option 8 was set to 1 since it indicated the
presence of a problem but without specifying its
extent.
3) The ICF categories with >50% missing values were
excluded from the analyses.
4) The missing values of the remaining ICF categories
were replaced five times by the Expectation-
Maximization (EM) algorithm. The percentage of the
missing data in each of these ICF categories is
presented in Table 2.
5) The response options for all ICF categories were
recoded 0–1, with 0 indicating no problem and 1
Table 2 The percentage of the missing data in each
variable included in the model before multiple
imputation*
Labels %
missing
T0
%
missing
T1
%
missing
T2
Energy and drive functions 2.0 29.5 34.3
Sleep functions 0.4 26.5 32.0
Attention functions 0.3 26.5 32.0
Memory functions 0.4 26.5 32.1
Emotional functions 0.5 26.6 32.3
Sensation of pain 1.3 27.1 32.3
Weight maintenance functions 3.4 32.0 36.5
Watching 0.4 26.7 32.8
Listening 2.4 29.5 35.1
Solving problems 1.2 27.6 33.3
Communicating with - receiving -
spoken messages
0.7 26.9 32.7
Speaking 2.1 28.8 34.1
Conversation 0.1 26.7 32.3
Lifting and carrying objects 1.1 28.3 34.3
Walking 0.9 26.9 32.3
Using transportation 2.4 31.3 36.2
Washing oneself 0.5 26.6 32.0
Caring for body parts 1.3 29.9 35.8
Dressing 0.7 27.1 32.9
Eating 0.7 26.9 32.4
Looking after one's health 2.2 28.4 34.4
Acquisition of goods and services 0.5 27.9 33.5
Preparing meals 1.3 29.8 35.6
Doing housework 0.8 29.2 34.1
Informal social relationships 1.5 27.9 32.5
Family relationships 1.2 30.0 34.9
Intimate relationships 1.3 29.1 34.4
Remunerative employment 1.6 27.4 33.5
Economic self-sufficiency 1.1 28.3 34.4
Community life 2.4 32.0 37.0
Recreation and leisure 1.3 27.4 33.1
Products or substances for
personal consumption
0.5 34.1 39.4
Immediate family 1.3 27.8 34.0
Individual attitudes of immediate
family members
2.2 30.6 36.1
Health services, systems and
policies
1.5 31.1 37.8
* For each ICF category, at least one value of the three time points of
assessment was available for each patient.
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categories barrier was recoded −1, not relevant 0
and facilitator 1.
6) The five imputed datasets were separately prepared
and the resulting datasets combined into a single
dataset used for the next step of the analyses.
Multilevel model for change
Multilevel models for change were performed using the
following steps to determine which ICF categories explain
the variability and change over time of the four health out-
comes in brain disorders (GH Scale, the PCS and the
MCS of the SF-36 as well as the WHODAS II score).
1) An individual growth model (the level-1 component
of the multilevel model) was fitted to describe the
overall trend over time in our health outcomes. This
method estimates the average trajectory as well as
individual trajectories, thereby allowing the explicit
examination of inter-individual differences in intra-
individual change.
2) A level-2 submodel of the multilevel model that
describes how the changes vary across patients
was fitted introducing the time-invariant variables
(age, gender and health condition) and the
time-varying variable (disease severity) as
predictors. They were kept in the model whether
or not they had significant influence. The
reference value for gender was male, the reference
population for brain disorders was stroke, and the
reference value for disease severity was the
highest level of severity.
3) To identify which ICF category was the most
predictive confounding variable or effect modifier of
the health outcome, each ICF category was
introduced (both itself and in interaction with time)
in the model that resulted from step 2. Thus, as
many models as ICF categories were created. The
smaller the Akaike's Information Criterion (AIC)
of the model the better predictor the
corresponding ICF category. For the best
predictor, the best model was selected based on
the following criterion:If a) both estimates for the ICF category itself and for
the interaction with time were significant, or b) only
the interaction with time was significant, then both
terms were entered in the model. If c) only the
estimate for the ICF category itself was significant, then
only this term was entered in the model.
The resulting model was used as a starting point for
the next step.
To identify in which sequence further ICF categories
were introduced in the final model, step 3 was repeated
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preceding model already containing the ICF categories
selected in previous steps.
4) The selection procedure was stopped if the ICF
category last entered into the model was not
significant or if an ICF category already included into
the model became non-significant.
Data analysis was performed with SAS version 9.2.
Results
The demographic information of the study population as
well as the descriptive statistics of the four health out-
comes at each time point of assessment are presented in
Table 3.
The data of 741 patients with brain disorders was
collected. Depending on the amount of missing
values in each health outcome, the corresponding
sample sizes in the different models were different:
445 for GH Scale, 402 for MCS, 402 for PCS, and
415 for WHODAS II score. The distribution of per-
sons per health outcome and condition is presented
in Table 4.
The boxplots presented in Figure 2 show how much
change there is in the self-reported health outcomes
over time.
One hundred and three ICF categories had >50% of
missing values and were excluded from the analyses.
The EM algorithm was used to replace missing values in
the remaining 35 ICF categories which were used as po-
tential predictors in the multilevel model for change: 7
ICF categories from the component body functions, 24
ICF categories from the component activities and par-
ticipation, and 4 ICF categories from the component en-
vironmental factors.
Using the individual growth model, the development
over time in the MCS and WHODAS II score can be de-
scribed by a “linear change trajectory”, while in the GH
Scale by a “quadratic change trajectory”.
Since time was not a significant predictor in the indi-
vidual growth model for PCS, no multilevel model for
change was calculated for this health outcome.
The three final multilevel models for change for GH
Scale, MCS and WHODAS II score are presented in
Table 5. For each of the independent variables included
in the model the parameter estimate and its standard
error (SE) are reported. Significant coefficients are
marked in the table with * or **.
Age was a significant predictor for GH Scale and
WHODAS II score, with higher age being related to
worse health.Compared to stroke, the reference health condition,
the regression coefficients for all other brain disor-
ders indicate significantly better health for MCS. For
WHODAS II score, the regression coefficients for all
other brain disorders, except depression, indicate signifi-
cantly better health. Regarding the GH Scale, the regres-
sion coefficients for bipolar disorders, migraine and TBI
indicate significantly better health than for stroke.
Four ICF categories of the component body functions
were selected as significant predictors in relation to at
least one health outcome, namely Energy and drive func-
tions and Emotional functions for GH Scale and MCS,
Sleep functions for MCS and Sensation of pain for MCS.
All estimates but the one of Sensation of pain indicate
that problems in these ICF categories are associated to
lower health.
Attention functions, Memory functions and Weight
maintenance functions were the body functions which
were included in the analyses but not selected as signifi-
cant predictors.
In the component activities and participation, 10 out
of the original 24 ICF categories were selected as signifi-
cant predictors for at least one of the three health out-
comes. Solving problems was a significant predictor for
MCS and WHODAS II score and also of the rate of
change in WHODAS II score.
Conversation and Washing oneself were significant pre-
dictors for WHODAS II score, Lifting and carrying
objects and Using transportation for GH Scale and Ac-
quisition of goods and services and Recreation and leisure
for MCS. Walking and Informal social relationships were
significant predictors for GH Scale and WHODAS II
score. Finally, Community life was a significant predictor
for GH Scale and MCS.
For all selected ICF categories of the component activ-
ities and participation but the interaction term of Solv-
ing problems and time it applies that having a problem
in them is related to poorer health.
The 14 ICF categories of the component activities and
participation that were not significant predictors for any
of the health outcomes were: Watching, Listening, Com-
municating with -receiving - spoken messages, Speaking,
Caring for body parts, Dressing, Eating, Looking after
one's health, Acquisition of goods and services, Doing
housework, Family relationships, Intimate relationships,
Remunerative employment, and Economic self-sufficiency.
In the component environmental factors, Products or sub-
stances for personal consumption and its rate of change were
significant predictors for MCS and Health services, systems
and policies was a significant predictor for GH Scale.
The two environmental factors that were not selected
as significant predictors for any of the health outcomes
were: Immediate family and Individual attitudes of
immediate family members.
Table 3 Study population demographic information and descriptive statistics of the four health outcomes at each time
point of assessment
Patient characteristics N = 741
Female patients; n (%) 498 (53.7%)
Age: years; mean (sd) 50 (15.6)
Yrs of formal education: yrs;
mean (sd); median
13 (4.4); 13
Current occupation
Government employee; % 12.6
Non-government employee; % 24.08
Self-employed; % 7.9
Employer; % 1
Not working for pay; % 54.4
Health outcomes based on SF-36 and WHODAS II Score
Time of assessment GH Scale
(N = 445)
PCS
(N = 402)
MCS
(N = 402)
WHODAS II Score
(N = 415)
Time 0; mean (sd) 52.60 (21.70) 45.79 (10.35) 40.14 (14.27) 26.89 (19.72)
Time 1; mean (sd) 56.19 (21.33) 45.78 (10.29) 43.23 (12.02) 21.11 (17.13)
Time 2; mean (sd) 56.18 (21.17) 45.60 (10.52) 44.84 (11.43) 19.98 (16.69)
GH = General Health; PCS = Physical Component Summary; MCS =Mental Component Summary.
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each health outcome before introducing ICF categor-
ies in the model and for the final model is reported
in Table 6. Variance estimates of random effects and
goodness-of-fit statistics are reported for each model.
For assessing goodness-of-fit, the models are com-
pared to the corresponding individual growth model.
For each parameter its mean and the mean of its
standard errors (SE) over the five imputed datasets
are reported. The deviance and the AIC reflect the
fit of the models. Model fit always improves when
adding the ICF categories.
Discussion
This study identified a set of psychosocial difficulties
that are associated with short term changes in health
outcomes in a group of heterogeneous brain disorders.Table 4 Distribution of persons per health outcome and
condition
Brain Disorder GH Scale MCS PCS WHODAS II Score
Bipolar Disorders 73 73 73 74
Depression 63 62 62 64
Migraine 84 84 84 81
Multiple Sclerosis 36 35 35 37
Parkinson's Disease 60 60 60 44
Stroke 77 36 36 65
Traumatic Brain Injury 52 52 52 50
Total 445 402 402 415These psychosocial difficulties are: sensation of pain,
mental functions such as energy and drive functions,
sleep and emotional functions, as well as a broad range
of activities and participation domains, including solving
problems, conversation, areas of mobility and self-care,
relationships, community life and recreation and leisure.
In clinical practice, these difficulties can be used as the
basis for a description of the difficulties in people’s lives
associated to these conditions and to make comparisons
among them. In this context it is important to mention
that all identified ICF categories (with the exception of
vision) were included in the World Health Survey
(WHS) used by the WHO in its 2000 report on health
system performance assessment [21] and in the World
Mental Health Surveys [22], in both cases to compare
disability across conditions at the population level. The
WHO set of domains (mobility, self-care, pain and dis-
comfort, cognition, interpersonal activities, vision, sleep,
energy, and affect) has not been further validated across
populations. Even though the validation of the WHS set
of domains was not an aim of this study, our results do
show that these domains are relevant to a broad range
of heterogeneous clinical samples with brain disorders.
The fluctuations in the health outcomes GH Scale,
MCS and the WHODAS II score when measured over
short periods of time were small. This means that to
determine whether greater changes over time in the dis-
orders take place, cohort studies that followed patients
over much longer periods of time, most likely years,
would be needed. Large sample studies of this sort in-
volving patients with a number of brain disorders
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Figure 2 Boxplots showing extent of change in GH Scale, PCS, MCS and WHODAS II Score over time.
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There is, however, at least one coordination action
at the European level currently being carried out
to address the changes in psychosocial difficulties
of brain disorders over time (PARADISE www.
paradiseproject.eu). PARADISE is currently testing
an innovative approach to collecting clinical data on
the psychosocial difficulties that people experience
when they suffer from brain disorders, the determi-
nants of the occurrence of those difficulties and the
determinants of their change over time. The results
of this project will be available mid-2013. In
addition, the results show that it will be important
to analyze whether both outcomes related to mental
health and physical health vary over time and
whether different psychosocial domains predict these
changes.
All the models improved after introducing the ICF
categories, and some of these results need special
comment:By introducing eight ICF categories – energy and drive
functions, emotional functions, lifting and carrying ob-
jects, walking, using transportation, informal social rela-
tionships, community life and health services, systems
and policies – to time, gender, age, health condition and
disease severity, it is possible to explain the variation
among patients in self-reported general health. This sug-
gests that both bodily domains (energy and drive, emo-
tional functions, carrying objects, walking and using
transportation) and the more social domains (informal
social relationships and community life) need to be con-
sidered in order to adequately describe the experience of
general health for persons with brain disorders, and
thereby to gain the advantages for intervention planning
and other applications of a more extensive understand-
ing of this experience.
Similarly, model fit of self-report mental health was
shown to be improved after introducing a broad range of
variables that included sleep functions, solving problems,
conversation, acquisition of goods and services and drugs.
Table 5 Final multilevel models for change for each health outcome
GH Scale MCS WHODAS II Score
Estimate SE Estimate SE Estimate SE
Intercept 55.50** 2.58 32.20** 1.94 31.22** 1.73
Time in Days 0.06* 0.02 0.07** 0.01 −0.02* 0.01
Time in Days squared −0.0006* 0.0002
Gender 0.23 1.76 −1.55 0.85 −0.89 1.14
Age −0.17* 0.06 −0.04 0.03 0.08* 0.04
Bipolar Disorders 8.92* 3.24 13.62** 1.71 −13.87** 2.07
Depression 3.43 3.31 5.34* 1.94 −3.64 2.11
Migraine 7.66* 3.11 12.82** 1.64 −16.63** 2.03
Multiple Sclerosis −1.58 3.71 10.66** 1.95 −15.60** 2.40
Parkinson’s Disease 2.29 3.10 17.56** 1.63 −22.81** 2.04
Traumatic Brain Injury 18.36** 3.48 19.49** 1.89 −18.71** 2.26
Mild Disease Severity 6.96** 1.57 5.69** 0.87 −8.10** 1.05
Moderate Disease Severity 3.01* 1.33 2.96** 0.77 −3.57** 0.94
Energy and drive functions −4.73** 1.10 −2.60** 0.64
Sleep functions −2.43** 0.59
Emotional functions −3.73* 1.18 −4.33** 0.69
Sensation of pain 2.15* 0.70
Solving problems −3.48** 0.66 7.75** 1.02
Solving problems * Time in days −0.03* 0.01
Conversation 4.59** 0.83
Lifting and carrying objects −4.13* 1.17
Walking −4.54** 1.15 7.67** 0.79
Using transportation −4.06* 1.58
Washing oneself 8.28** 0.91
Acquisition of goods and services −1.99* 0.68
Informal social relationships −3.95* 1.24 5.21** 0.89
Community life −5.54** 1.22 −3.64** 0.68
Recreation and leisure −2.57** 0.63
Products or substances for personal
consumption
4.72** 1.06
Products or substances for personal
consumption * Time in days
−0.07** 0.01
Health services, systems and policies 3.05* 1.01
*P < 0.05, **P < 0.001.
Column ‘Estimate’ contains the mean of the regression coefficients and the column ‘SE’ the standard error of those estimates.
The estimates have to be interpreted with respect to the reference values, which were male for gender, stroke for the brain disorder, and ‘high’ for disease
severity. For the ICF categories the reference value is not having a problem.
While positive estimates in the GH Scale and MCS indicate better health, they indicate lower health in the WHODAS II score.
The SE has to be interpreted in such a way that the smaller the SE, the more precise is the estimation of the regression coefficients.
The parameter estimate and the standard error (SE) for each of the independent variables are reported.
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psychosocial domains mentioned are included in the
SF-36 [23], which underscores the importance of informa-
tion about social domains, as well as mental domains, for
the overall description of mental health in brain disorders.
The psychosocial difficulties that contribute to the im-
provement of the model fit of the WHODAS IIsummary score are difficulties covered by questions in
this questionnaire, so it should not come as a surprise
that they were selected in the regression model. It is im-
portant to mention that solving problems helps to ex-
plain the variability over time of the WHODAS II
summary score. Solving problems is a domain of activity
and participation that is not consistently taken into
Table 6 Comparison of multilevel models for change for each health outcome before introducing ICF categories in the
model and for the final model
GH Scale MCS WHODAS II Score
Before
introducing
ICF categories
Final model Before
introducing
ICF categories
Final model Before
introducing
ICF categories
Final model
Variance estimates of random effects: mean (SE)
Intercept 267.81** (22.01) 211.96** (17.75) 52.27** (5.63) 35.94** (3.76) 127.63** (12.95) 72.65** (7.38)
Residual 130.02** (6.61) 115.79** (5.90) 57.41** (3.09) 42.24** (2.25) 78.08** (4.15) 55.42** (2.95)
Goodness-of-Fit: mean (SE)
Deviance (−2 Log Likelihood) 10250.08 (3.98) 10110.68 (4.67) 8148.10 (2.60) 7798.55 (4.34) 8965.81 (3.27) 8496.80 (8.56)
Number of Parameters 16 24 15 25 15 21
Chi-square statistic(Degrees of freedom) 11.82** (10) 251.22** (18) 262.92** (10) 612.47** (20) 261.96** (10) 730.97** (16)
AIC 10282.08 (3.98) 10062.68 (4.67) 8118.10 (2.60) 7748.55 (4.34) 8935.81 (3.27) 8454.80 (8.56)
The deviance and Akaike’s Information Criterion (AIC). The smaller the deviance and the AIC the better the model fits the data.
*P < 0.05, **P < 0.001.
Variance estimates of random effects and goodness-of-fit statistics are reported for each model. For assessing goodness-of-fit the models are compared to the
corresponding individual growth model. For each parameter its mean and the mean of its standard errors (SE) over the five imputed datasets are reported.
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ders. Our investigation provides some evidence that this
domain is an important psychosocial difficulty relevant
to a comprehensive description of the experience of liv-
ing with a brain disorder.
The relationship between the disability measured with
the WHODAS II and with the SF-36 in brain disorders
has already been evaluated in two papers on depression
and migraine [24,25]. Results from these studies account
for mild to moderate correlations between these ques-
tionnaires, thus confirming that both measure difficulties
related to different psychosocial problems, and that mea-
sures of psychosocial difficulties should be employed in
clinical and public health research using a cross-cutting
perspective, and not only a disease-specific one.
Finally, this study shows that it is useful to use the ICF
as a source of independent variables for longitudinal
studies and as a basis for defining psychosocial difficul-
ties. Using ICF made it possible for us to analyze to-
gether the data derived from different brain disorders.
Psychosocial difficulties were conceptualized in terms of
ICF as disabilities arising from the interaction of the
brain disorder and personal and environmental factors.
They represent impairments, activity limitations and
participation restrictions. Impairments and activity limi-
tations are decrements of functioning capacity, and so
are elements of a person’s health state. Participation re-
strictions go beyond the health state to include restric-
tions in a person’s performance of actions, tasks and
behaviors in his or her actual environment [26].
We have shown that psychosocial difficulties must not
be defined solely in terms of the health conditions that
produce decreases in functioning in various domains,
but also in terms of the physical, social and attitudinal
environment, which, when taken into account,contributes to explain the impact of brain disorders on
people’s lives. The social and attitudinal environment,
especially in the case of brain disorders, includes barriers
such as fear, misunderstanding, stigma and discrimination
[27-30], as well as the absence of social policies to accom-
modate people with brain disorders in the workplace and
elsewhere in society [31,32].
Against our expectations, in this study three environ-
mental factors - Immediate family, Individual attitudes
of immediate family members and Health services, sys-
tems and policies - were not selected in the corres-
ponding models as significant independent variables.
There are potentially many reasons for this, including of
course limitations of our study design, such as having to
collapse the response options of the ICF qualifiers from
0 to 4 to the dichotomous, 0 and 1. Doing so resulted in
a loss of variability, and consequently sensitivity to
change. The collapsing was performed because model
complexity would have greatly increased if the ICF cat-
egories had been used as categorical variables with 5 and
9 response options, respectively, and for each response
option, interaction with time would have to have been
separately considered. A second limitation of the study
that should be mentioned is the irregularity with which
the time points of assessment are spaced. This irregular-
ity was due to practical considerations, such as the time
in which the health professionals could access the pa-
tients’ clinical records and performed the interviews.
Nevertheless, the irregular time points of assessment
across patients do not put into question the validity of
the results, since time in days has been included as a
metric variable in the multilevel models for change. Fi-
nally, 103 ICF categories had >50% of missing values
and were excluded from the analyses. As mentioned
before, we followed the recommendations of WHO and
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are documented. Thus, we assume that the ICF categor-
ies excluded from the analyses refer to issues that are
not relevant for the large majority of the patients and
therefore the validity of the results is not compromised.
However, we cannot deny that the decisions of the
health professionals regarding the relevance for the pa-
tients of areas addressed by ICF categories is fallible,
which might have influenced the validity of the data at
the end. For future studies, we recommend that the
same ICF categories always be evaluated for all the pa-
tients included in the study.
Conclusion
Our findings are of primary interest to researchers and
clinicians as they summarize a comprehensive list of
relevant psychosocial difficulties that explain the vari-
ability in health outcomes. Our study also indicates that
there is an explanatory role for fundamental human
relationships in accounting for changes over time. In
addition to difficulties that are frequently part of diag-
nostic criteria, such as emotional and energy and drive
functions, there are other fundamental difficulties that a
wide range of brain disorders share. This study is an
early attempt to identify the influence of these difficul-
ties over time using the comprehensive framework of
the ICF. Further longitudinal studies are obviously
needed to map out both the patterns and the variations
in the experience of living with a brain disorder.
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